Review of the Week
Global share markets struggled to hold on to early gains this week, as relations between the US and China hit a new low and the US economy showed signs of deteriorating.
UK shares started the week on the back foot, with the FTSE100 closing down 0.5% due to worries about rising coronavirus cases and protracted EU negotiations about its economic recovery package. Shares in Europe closed up on hopes of a deal on the emergency stimulus package and… Continue reading
Global share markets have largely risen this week as several vac- cines produced encouraging results in early trials. A vaccine from Oxford University appears to have stimulated antibodies and T-cells in trials on 1,000 volunteers. T-cells are important because they can last for years while virus antibodies are thought to last only a few months. Meanwhile, US biotech company Moderna said its vaccine led to a “robust” immune response. A trial involving 30,000 Ameri- cans is due to… Continue reading
Share markets have been mixed this week as equities in China have surged as confidence in its recovery increases. The Shanghai Composite has increased by 11.6% in the past week, while most other markets have been struggling for traction amid a flow of downbeat Covid-related news.
The oil price has slipped on the prospect of renewed lockdowns in the US, while the price of gold, perceived as a safe haven and hedge against inflation, rose above $1,800 for… Continue reading
Share markets pushed higher this week as encouraging news emerged about possible vaccines, followed by a better-than-expected jobs report in the US on Thursday. It was enough to renergise the bullish mood, despite the worsening Covid situation and renewed lockdowns in parts of the US.
On Monday, UK equities finished higher, with the FTSE100 up by 1.1% despite growing concerns about the US with numerous states setting new records for infections. BP was a standout gainer, up 3.4%,… Continue reading